Forte Biosciences Inc
Stock Chart, Company Information, and Scan Results
$36.70(as of Jul 9, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Forte Biosciences Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$36.70
Ticker SymbolFBRX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees22
CountyUSA
Market Cap$455.7M
EBIDTA-76.9M
P/E Ratio-86.30
Forward P/E Ratio0.00
Earnings per Share-4.97
Profit Margin-Infinity%
RSI81.86
Shares Outstanding20.5M
ATR2.88
52-Week High35.80
Volume4,827,609
52-Week Low9.10
Book Value42.1M
P/B Ratio155.49
Upper Keltner26.57
P/S RatioInfinity
Lower Keltner13.62
Debt-to-Equity Ratio26.57
Next Earnings Date08/12/2026
Cash Surplus34.6M
Next Ex-Dividend DateUnknown
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
Forte Biosciences Inc In Our Stock Scanner
As of Jul 10, 2026
Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
Scan Name: 52-Week HighScan Type: Stock Fundamentals
As of ---
Scan Name: Most Volatile StocksScan Type: Stock Indicator Scans
As of ---
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.